...
首页> 外文期刊>Experimental parasitology >Plasmodium berghei: parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model
【24h】

Plasmodium berghei: parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model

机译:伯氏疟原虫:在非典鼠疟疾模型中用双氢青蒿素治疗后的寄生虫清除率

获取原文
获取原文并翻译 | 示例
           

摘要

Clinical reports indicate that malaria-infected asplenic patients have a reduced capacity for parasite clearance despite intensive antimalarial therapy. The aim of this study was to evaluate the efficacy of dihydroartemisinin in an asplenic murine malaria model. Mice were inoculated with Plasmodium berghei parasitised erythrocytes and received a single dose of dihydroartemisinin 56 h later, at 2-5% parasitaemia. Haematology, liver biochemistry and histopathology of key organs were performed to evaluate organ response to malaria infection. The nadir parasitaemia occurred 20 h after dihydroartemisinin administration, falling 2.8- to 6.0-fold and 2.7- to 6.9-fold in asplenic and intact mice, respectively, (10-100 mg/kg). Histopathology indicated increased stimulation of liver function/activity during malaria infection of asplenic mice (as compared to intact mice). Overall efficacy of single-dose dihydroartemisinin treatment in asplenic mice was similar to intact mice although the rate of recrudescence in asplenic mice was significantly greater than intact mice at 30 and 100 mg/kg. The asplenic murine malaria model could be used in pre-clinical studies of splenic function and clearance of malaria parasites, pathophysiological studies or antimalarial drug efficacy in asplenia.
机译:临床报告表明,尽管加强了抗疟疾治疗,但感染疟疾的麻痹患者的寄生虫清除能力却下降了。这项研究的目的是评估双氢青蒿素在非典鼠疟疾模型中的功效。小鼠用伯氏疟原虫寄生的红细胞接种,并在56小时后以2%至5%的寄生虫血症接受单剂量的双氢青蒿素。进行血液学,肝脏生物化学和关键器官的组织病理学以评估器官对疟疾感染的反应。双氢青蒿素给药后20小时出现最低点寄生虫血症,在无脾和完整小鼠(10-100 mg / kg)中分别下降了2.8-6.0倍和2.7-6.9倍。组织病理学表明,在脾脏小鼠疟疾感染期间(与完整小鼠相比)对肝功能/活动的刺激增加。尽管在30和100 mg / kg的条件下,单倍剂量双氢青蒿素在脾脏小鼠中的总体治疗效果与完整小鼠相似,但其复发率明显高于完整小鼠。脾虚小鼠疟疾模型可用于脾功能和清除疟疾寄生虫的临床前研究,病理生理研究或抗疟疾的抗疟药功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号